BMED Stock Overview
Banca Mediolanum S.p.A. provides various banking products and services in Italy.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 3/6 |
Dividends | 4/6 |
Banca Mediolanum S.p.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €9.87 |
52 Week High | €10.38 |
52 Week Low | €7.61 |
Beta | 1.32 |
1 Month Change | -4.04% |
3 Month Change | 5.43% |
1 Year Change | 18.43% |
3 Year Change | 25.83% |
5 Year Change | 50.92% |
Change since IPO | 34.43% |
Recent News & Updates
Recent updates
Shareholder Returns
BMED | AT Diversified Financial | AT Market | |
---|---|---|---|
7D | -1.3% | -1.7% | -0.04% |
1Y | 18.4% | 3.7% | 2.2% |
Return vs Industry: BMED exceeded the Austrian Diversified Financial industry which returned 3.7% over the past year.
Return vs Market: BMED exceeded the Austrian Market which returned 2.2% over the past year.
Price Volatility
BMED volatility | |
---|---|
BMED Average Weekly Movement | 2.4% |
Diversified Financial Industry Average Movement | 3.9% |
Market Average Movement | 3.3% |
10% most volatile stocks in AT Market | 5.0% |
10% least volatile stocks in AT Market | 1.6% |
Stable Share Price: BMED has not had significant price volatility in the past 3 months.
Volatility Over Time: BMED's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1982 | 3,566 | Massimo Doris | www.bancamediolanum.it |
Banca Mediolanum S.p.A. provides various banking products and services in Italy. The company offers current accounts; deposits; and mortgages and loans. It also provides debit, credit, and prepaid cards; investment products, such as mutual funds, unit linked policies, investment strategies, other investments, trading, and retirement products; and life insurance products and services.
Banca Mediolanum S.p.A. Fundamentals Summary
BMED fundamental statistics | |
---|---|
Market cap | €7.24b |
Earnings (TTM) | €821.90m |
Revenue (TTM) | €1.80b |
8.8x
P/E Ratio4.0x
P/S RatioIs BMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BMED income statement (TTM) | |
---|---|
Revenue | €1.80b |
Cost of Revenue | €0 |
Gross Profit | €1.80b |
Other Expenses | €979.80m |
Earnings | €821.90m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.11 |
Gross Margin | 100.00% |
Net Profit Margin | 45.62% |
Debt/Equity Ratio | 288.3% |
How did BMED perform over the long term?
See historical performance and comparison